JP2021119789A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021119789A5 JP2021119789A5 JP2021083406A JP2021083406A JP2021119789A5 JP 2021119789 A5 JP2021119789 A5 JP 2021119789A5 JP 2021083406 A JP2021083406 A JP 2021083406A JP 2021083406 A JP2021083406 A JP 2021083406A JP 2021119789 A5 JP2021119789 A5 JP 2021119789A5
- Authority
- JP
- Japan
- Prior art keywords
- fistula
- agent according
- agent
- mixed
- express
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003795 chemical substances by application Substances 0.000 claims 12
- 206010016717 Fistula Diseases 0.000 claims 8
- 230000003890 fistula Effects 0.000 claims 8
- 238000002560 therapeutic procedure Methods 0.000 claims 4
- 208000011231 Crohn disease Diseases 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 3
- 102000006639 indoleamine 2,3-dioxygenase Human genes 0.000 claims 3
- 108020004201 indoleamine 2,3-dioxygenase Proteins 0.000 claims 3
- -1 CD11c Proteins 0.000 claims 2
- 210000000577 adipose tissue Anatomy 0.000 claims 2
- 230000000735 allogeneic effect Effects 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229960003444 immunosuppressant agent Drugs 0.000 claims 2
- 239000003018 immunosuppressive agent Substances 0.000 claims 2
- 102100022464 5'-nucleotidase Human genes 0.000 claims 1
- 102100032912 CD44 antigen Human genes 0.000 claims 1
- 102100022002 CD59 glycoprotein Human genes 0.000 claims 1
- 102100037241 Endoglin Human genes 0.000 claims 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims 1
- 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 claims 1
- 101000881679 Homo sapiens Endoglin Proteins 0.000 claims 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 1
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 claims 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 1
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims 1
- 102100022338 Integrin alpha-M Human genes 0.000 claims 1
- 102100022297 Integrin alpha-X Human genes 0.000 claims 1
- 102100025304 Integrin beta-1 Human genes 0.000 claims 1
- 102100037850 Interferon gamma Human genes 0.000 claims 1
- 108010074328 Interferon-gamma Proteins 0.000 claims 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims 1
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 claims 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 1
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 230000001861 immunosuppressant effect Effects 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1604304.4 | 2016-03-14 | ||
| GBGB1604304.4A GB201604304D0 (en) | 2016-03-14 | 2016-03-14 | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
| JP2018548356A JP6931656B2 (ja) | 2016-03-14 | 2017-03-14 | クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548356A Division JP6931656B2 (ja) | 2016-03-14 | 2017-03-14 | クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021119789A JP2021119789A (ja) | 2021-08-19 |
| JP2021119789A5 true JP2021119789A5 (enExample) | 2021-09-30 |
Family
ID=55952284
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548356A Active JP6931656B2 (ja) | 2016-03-14 | 2017-03-14 | クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞 |
| JP2021083406A Pending JP2021119789A (ja) | 2016-03-14 | 2021-05-17 | クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548356A Active JP6931656B2 (ja) | 2016-03-14 | 2017-03-14 | クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞 |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US10357518B2 (enExample) |
| EP (2) | EP4074322A1 (enExample) |
| JP (2) | JP6931656B2 (enExample) |
| KR (1) | KR102277789B1 (enExample) |
| CN (2) | CN115569151A (enExample) |
| AU (1) | AU2017232718B2 (enExample) |
| BE (1) | BE1024781B1 (enExample) |
| CA (1) | CA3017694C (enExample) |
| CY (1) | CY1125513T1 (enExample) |
| DE (1) | DE102017002458B4 (enExample) |
| DK (1) | DK3219321T3 (enExample) |
| ES (2) | ES2911718T3 (enExample) |
| FR (1) | FR3048614B1 (enExample) |
| GB (2) | GB201604304D0 (enExample) |
| HR (1) | HRP20220539T1 (enExample) |
| HU (1) | HUE058739T2 (enExample) |
| IL (2) | IL298107B2 (enExample) |
| LT (1) | LT3219321T (enExample) |
| MX (1) | MX2018010699A (enExample) |
| NL (1) | NL2018512B1 (enExample) |
| NO (1) | NO345415B1 (enExample) |
| PL (1) | PL3219321T3 (enExample) |
| RS (1) | RS63163B1 (enExample) |
| RU (1) | RU2742308C2 (enExample) |
| SG (2) | SG10202008992YA (enExample) |
| SI (1) | SI3219321T1 (enExample) |
| WO (1) | WO2017158509A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060045872A1 (en) | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
| GB201604304D0 (en) * | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
| AU2018244922A1 (en) | 2017-03-30 | 2019-09-12 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with live biotherapeutics |
| CN113544261B (zh) * | 2019-02-27 | 2024-10-01 | 武田药品工业株式会社 | 用于同种异体疗法的改良的干细胞群 |
| WO2021180850A1 (en) * | 2020-03-11 | 2021-09-16 | Mesoblast International Sàrl | Method for treating inflammatory bowel disease i |
| BR112022018022A2 (pt) * | 2020-03-11 | 2022-10-18 | Mesoblast Int Sarl | Método para tratar doença inflamatória intestinal ii |
| CN111481573A (zh) * | 2020-03-26 | 2020-08-04 | 卡替（上海）生物技术股份有限公司 | 牙髓间充质干细胞在制备克罗恩病治疗药物中的用途 |
| CA3200227A1 (en) * | 2020-11-25 | 2022-06-02 | Alexandra Sophie DE BOER | Adipogenic cell compositions and methods |
| WO2023230524A1 (en) * | 2022-05-25 | 2023-11-30 | Flagship Pioneering Innovations Vi, Llc | Compositions of secretory and/or catalytic cells and methods using the same |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5733542A (en) | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
| US6010696A (en) | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| FR2680931B1 (fr) | 1991-08-27 | 1997-08-14 | Thomson Csf | Procede de detection et de suivi d'objets en mouvement par analyse de sequences d'images. |
| BR9307550A (pt) | 1992-12-02 | 1999-05-25 | Shell Int Research | Composto fungicida processo para a preparação de um composto fungicida composição fungicida processo de combate aos fungos em um local e uso |
| WO1995002698A1 (en) | 1993-07-12 | 1995-01-26 | Life Technologies, Inc. | Composition and methods for transfecting eukaryotic cells |
| US5472183A (en) | 1994-03-17 | 1995-12-05 | Nisca Corporation | Sheet feeding device with multiple sheet stackers |
| JPH10505250A (ja) | 1994-06-06 | 1998-05-26 | ケース ウエスターン リザーブ ユニバーシティ | 組織再生のためのバイオマトリックス |
| US6174333B1 (en) | 1994-06-06 | 2001-01-16 | Osiris Therapeutics, Inc. | Biomatrix for soft tissue regeneration using mesenchymal stem cells |
| US6051429A (en) | 1995-06-07 | 2000-04-18 | Life Technologies, Inc. | Peptide-enhanced cationic lipid transfections |
| DE69634084T2 (de) | 1995-06-07 | 2005-12-08 | Inex Pharmaceuticals Corp. | Herstellung von lipid-nukleinsäure partikeln duch ein hydrophobische lipid-nukleinsäuree komplexe zwischenprodukt und zur verwendung in der gentransfer |
| US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
| US6546106B2 (en) | 1996-09-03 | 2003-04-08 | New Transducers Limited | Acoustic device |
| US5705308A (en) | 1996-09-30 | 1998-01-06 | Eastman Kodak Company | Infrared-sensitive, negative-working diazonaphthoquinone imaging composition and element |
| CN1166773C (zh) | 1997-12-02 | 2004-09-15 | 泽恩比奥公司 | 分离的人脂肪组织衍生的基质细胞 |
| US6368636B1 (en) | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| US9585916B2 (en) | 1999-03-26 | 2017-03-07 | Northern Therapeutics Inc. | Cell based therapy for the pulmonary system |
| US6797269B2 (en) | 1998-04-03 | 2004-09-28 | Osiris Therapeutics, Inc. | Mesenchymal stem cells as immunosuppressants |
| US6546105B1 (en) | 1998-10-30 | 2003-04-08 | Matsushita Electric Industrial Co., Ltd. | Sound image localization device and sound image localization method |
| US20050153442A1 (en) | 1999-03-10 | 2005-07-14 | Adam Katz | Adipose-derived stem cells and lattices |
| CN1352696A (zh) | 1999-03-10 | 2002-06-05 | 匹兹堡大学联邦制高等教育 | 脂肪来源的干细胞和网格 |
| US20030082152A1 (en) | 1999-03-10 | 2003-05-01 | Hedrick Marc H. | Adipose-derived stem cells and lattices |
| US6777231B1 (en) | 1999-03-10 | 2004-08-17 | The Regents Of The University Of California | Adipose-derived stem cells and lattices |
| CN1201268C (zh) | 1999-06-30 | 2005-05-11 | 国际商业机器公司 | 实现运动模糊化的图像处理 |
| US7670628B2 (en) | 1999-07-07 | 2010-03-02 | Angioblast Systems, Inc. | Mesenchymal precursor cell |
| US6555374B1 (en) | 1999-08-19 | 2003-04-29 | Artecel Sciences, Inc. | Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
| CA2438904C (en) | 2001-02-23 | 2012-09-04 | The University Of Pittsburgh | Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
| US20030054331A1 (en) | 2001-09-14 | 2003-03-20 | Stemsource, Inc. | Preservation of non embryonic cells from non hematopoietic tissues |
| JP2005533480A (ja) * | 2001-11-09 | 2005-11-10 | アーテセル・サイエンシズ・インコーポレーテツド | 脂肪組織由来間質細胞の膵内分泌分化およびその使用 |
| CN1596303A (zh) | 2001-11-09 | 2005-03-16 | 阿特塞尔科学公司 | 利用基质细胞支持胚胎干细胞和成体干细胞的方法和组合物 |
| US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
| US7282222B2 (en) | 2002-03-15 | 2007-10-16 | The United States Of America As Represented By The Department Of Veterans Affairs | Methods and compositions for directing cells to target organs |
| DE60318706T2 (de) | 2002-06-14 | 2009-04-30 | Cartela R & D Ab | Marker für stammzellen und dessen verwendung |
| US20040101959A1 (en) | 2002-11-21 | 2004-05-27 | Olga Marko | Treatment of tissue with undifferentiated mesenchymal cells |
| CA2521217C (en) | 2003-04-01 | 2013-05-14 | United States Of America Department Of Veteran's Affairs | Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| ES2265199B1 (es) | 2003-06-12 | 2008-02-01 | Cellerix, S.L. | Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones. |
| CA2530421C (en) | 2003-06-27 | 2015-04-21 | Ethicon, Incorporated | Repair and regeneration of ocular tissue using postpartum-derived cells |
| US7645229B2 (en) | 2003-09-26 | 2010-01-12 | Armstrong David N | Instrument and method for endoscopic visualization and treatment of anorectal fistula |
| US9074190B2 (en) | 2003-10-07 | 2015-07-07 | Biomaster, Inc. | Cell differentiation of adipose-derived precursor cells |
| DE602004030823D1 (de) | 2003-11-04 | 2011-02-10 | Biomaster Inc | Verfahren und system zur herstellung von stammzellen aus fettgewebe |
| US20080095749A1 (en) | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| EP2298861B1 (en) | 2004-03-22 | 2017-09-13 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
| RU2252252C1 (ru) | 2004-04-09 | 2005-05-20 | Тепляшин Александр Сергеевич | Способ выделения мезенхимальных стволовых клеток |
| ES2313805B1 (es) | 2004-10-04 | 2009-12-23 | Cellerix, S.L. | Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral. |
| US20060045872A1 (en) | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
| ES2264862B8 (es) | 2004-08-25 | 2017-01-20 | Cellerix, S.L. | Biomaterial para sutura. |
| US7732126B2 (en) | 2004-09-03 | 2010-06-08 | University Of Maryland, Baltimore | Integrin CD18 is a novel stromal stem cell marker and functions to promote osteogenesis |
| US20060286089A1 (en) | 2005-04-08 | 2006-12-21 | Xcyte Therapies, Inc. | Compositions and methods for the treatment of burns and sepsis |
| JP5925408B2 (ja) | 2005-09-23 | 2016-05-25 | タイジェニックス、ソシエダッド、アノニマ、ウニペルソナルＴｉｇｅｎｉｘ Ｓ．Ａ．Ｕ． | 免疫調節活性を有する細胞集団、単離方法および使用 |
| EP1795588A1 (en) | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| US20120269774A1 (en) | 2006-09-21 | 2012-10-25 | Medistem Laboratories, Inc | Allogeneic stem cell transplants in non-conditioned recipients |
| WO2009031606A1 (ja) | 2007-09-07 | 2009-03-12 | Jcr Pharmaceuticals Co., Ltd. | 関節炎治療及び予防剤 |
| CN107028981B (zh) | 2007-09-19 | 2021-04-20 | 普拉里斯坦有限公司 | 来自脂肪或胎盘组织的粘附细胞及其在治疗中的用途 |
| JP5539886B2 (ja) | 2007-10-17 | 2014-07-02 | ティクセル | Ｔｒ１細胞、間葉系幹細胞およびその使用 |
| GB0814249D0 (en) | 2008-08-04 | 2008-09-10 | Cellerix Sa | Uses of mesenchymal stem cells |
| ES2345867B1 (es) * | 2009-04-03 | 2011-07-28 | Fundacion Instituto Mediterraneo Para La Biotecnologia Y La Investigacion Sanitaria (Imabis) | Celulas madre multipotentes derivadas de estroma de mesenterio. |
| US20120020937A1 (en) * | 2009-04-28 | 2012-01-26 | Anterogen Co., Ltd. | Autologous and allogenic adipose-derived stromal stem cell composition for treating fistulas |
| KR101788885B1 (ko) | 2009-07-09 | 2017-10-20 | 타이제닉스, 에스.에이.유. | 세포 요법에 사용하기 위한 방법 및 조성물 |
| EP2649181B1 (en) * | 2010-12-06 | 2016-04-27 | Quark Pharmaceuticals, Inc. | Double stranded oligonucleotide compounds comprising positional modifications |
| EP2663316A2 (en) | 2011-01-12 | 2013-11-20 | TiGenix, S.A.U. | Adipose-derived mesenchymal stem cells for intralymphatic administration in autoimmune and inflammatory diseases |
| JP2014508527A (ja) | 2011-03-11 | 2014-04-10 | ティゲニクス、エセ、ア、ウ | 免疫調節活性を有する細胞集団、単離方法および使用 |
| US20140134140A1 (en) | 2012-11-09 | 2014-05-15 | Case Western Reserve University | Mesenchymal stem cell compositions for the treatment of microbial infections |
| AU2014230014B2 (en) | 2013-03-15 | 2019-11-14 | Tigenix, S.A.U. | Lymphocyte biomarkers for determining the clinical response to therapy with mesenschymal stromal cells(MSC) |
| JP6412933B2 (ja) | 2013-06-25 | 2018-10-24 | ティジェニクス エス．エー．ユー． | 免疫調節活性を有する細胞集団、その調製方法および使用 |
| SG11201610844PA (en) * | 2014-06-30 | 2017-01-27 | Tigenix S A U | Mesenchymal stromal cells for treating sepsis |
| WO2017051421A1 (en) * | 2015-09-24 | 2017-03-30 | Cellect Biotherapeutics Ltd. | Methods for propagating mesenchymal stem cells (msc) for use in transplantation |
| GB201604304D0 (en) * | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
| US10152822B2 (en) | 2017-04-01 | 2018-12-11 | Intel Corporation | Motion biased foveated renderer |
| US10890966B2 (en) | 2017-07-27 | 2021-01-12 | Arm Limited | Graphics processing systems |
| US10818080B2 (en) | 2018-07-25 | 2020-10-27 | Disney Enterprises, Inc. | Piecewise-polynomial coupling layers for warp-predicting neural networks |
| US11109065B2 (en) | 2018-09-26 | 2021-08-31 | Google Llc | Video encoding by providing geometric proxies |
-
2016
- 2016-03-14 GB GBGB1604304.4A patent/GB201604304D0/en not_active Ceased
-
2017
- 2017-03-14 HR HRP20220539TT patent/HRP20220539T1/hr unknown
- 2017-03-14 LT LTEP17160932.4T patent/LT3219321T/lt unknown
- 2017-03-14 AU AU2017232718A patent/AU2017232718B2/en active Active
- 2017-03-14 SG SG10202008992YA patent/SG10202008992YA/en unknown
- 2017-03-14 EP EP22163484.3A patent/EP4074322A1/en not_active Withdrawn
- 2017-03-14 JP JP2018548356A patent/JP6931656B2/ja active Active
- 2017-03-14 IL IL298107A patent/IL298107B2/en unknown
- 2017-03-14 IL IL261730A patent/IL261730B2/en unknown
- 2017-03-14 RS RS20220355A patent/RS63163B1/sr unknown
- 2017-03-14 EP EP17160932.4A patent/EP3219321B1/en active Active
- 2017-03-14 MX MX2018010699A patent/MX2018010699A/es unknown
- 2017-03-14 ES ES17160932T patent/ES2911718T3/es active Active
- 2017-03-14 SG SG11201807404XA patent/SG11201807404XA/en unknown
- 2017-03-14 FR FR1752073A patent/FR3048614B1/fr active Active
- 2017-03-14 HU HUE17160932A patent/HUE058739T2/hu unknown
- 2017-03-14 DK DK17160932.4T patent/DK3219321T3/da active
- 2017-03-14 KR KR1020187029414A patent/KR102277789B1/ko active Active
- 2017-03-14 RU RU2018131519A patent/RU2742308C2/ru active
- 2017-03-14 PL PL17160932T patent/PL3219321T3/pl unknown
- 2017-03-14 NL NL2018512A patent/NL2018512B1/nl active
- 2017-03-14 US US15/458,509 patent/US10357518B2/en active Active
- 2017-03-14 GB GB1704065.0A patent/GB2548490B/en active Active
- 2017-03-14 ES ES201700204A patent/ES2681774B1/es active Active
- 2017-03-14 DE DE102017002458.8A patent/DE102017002458B4/de active Active
- 2017-03-14 WO PCT/IB2017/051468 patent/WO2017158509A1/en not_active Ceased
- 2017-03-14 BE BE2017/5156A patent/BE1024781B1/de active IP Right Grant
- 2017-03-14 CN CN202211257331.4A patent/CN115569151A/zh active Pending
- 2017-03-14 CN CN201780017154.3A patent/CN108883135B/zh active Active
- 2017-03-14 CA CA3017694A patent/CA3017694C/en active Active
- 2017-03-14 SI SI201731122T patent/SI3219321T1/sl unknown
- 2017-03-14 NO NO20170376A patent/NO345415B1/en unknown
-
2019
- 2019-06-25 US US16/452,321 patent/US11273182B2/en active Active
-
2021
- 2021-05-17 JP JP2021083406A patent/JP2021119789A/ja active Pending
-
2022
- 2022-02-14 US US17/671,479 patent/US12213998B2/en active Active
- 2022-04-20 CY CY20221100296T patent/CY1125513T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021119789A5 (enExample) | ||
| JP2019508455A5 (enExample) | ||
| US20220088084A1 (en) | Uses of mesenchymal stem cells | |
| Liao et al. | Cells isolated from inflamed periapical tissue express mesenchymal stem cell markers and are highly osteogenic | |
| RU2018131519A (ru) | Стромальные стволовые клетки жировой ткани для использования в лечении рефракторных сложных перианальных фистул при болезни крона | |
| Kong et al. | Transplantation of hepatocyte growth factor–modified dental pulp stem cells prevents bone loss in the early phase of ovariectomy-induced osteoporosis | |
| Canham et al. | The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019 | |
| JP2023517641A (ja) | 炎症性腸疾患を治療するための方法ｉｉ | |
| AU2024227208A1 (en) | Treatment of diseases of endothelial dysfunction and inflammation | |
| Kim et al. | Longitudinal monitoring adipose-derived stem cell survival by PET imaging hexadecyl-4-124I-iodobenzoate in rat myocardial infarction model | |
| CN115361957A (zh) | 治疗炎症性肠病的方法i | |
| CN106062184B (zh) | 牙源性干细胞和基因修饰的牙源性干细胞的用途 | |
| KR101774751B1 (ko) | Il-17 산생 억제 조성물 | |
| Miloradovic et al. | Therapeutic efficacy of mesenchymal stem cells for cardiovascular diseases | |
| Ishii | Stem Cell Therapy and Regenerative | |
| KR101382566B1 (ko) | 태반 양막 유래 중간엽 줄기세포의 배양방법 및 말초 동맥 질환 치료법 및 조성물 | |
| Kudoh et al. | Pneumomediastinum, subcutaneous emphysema, and pulmonary fibrosis in a patient with idiopathic pneumonia syndrome after bone marrow transplantation | |
| MX2024008454A (es) | Combinacion de budesonida y 5-amino-2,3-dihidro-1,4-ftalazinadiona . | |
| Nakako et al. | Successful treatment with mesenchymal stem cells for steroid-refractory late-onset idiopathic pneumonia syndrome following allogeneic hematopoietic cell transplantation | |
| Lixin et al. | Clinical study of human umbilical cord blood stem cell transplantation via peripheral vein in the treatment of decompensated cirrhosis | |
| Zhou et al. | Bone marrow mesenchymal stem cells transplantation for the treatment of sclerodermatous chronic graft-versus-host disease: Immunologic mechanism changes in 4 cases | |
| BR112018068493B1 (pt) | Uso de células-tronco estromais | |
| Adila et al. | Myocardial revascularization after myocardial infarction using endothelial progenitor cells combined with fibrin gel | |
| Bersenev | Study of migration and homing of bone marrow cells into the myocardium after a heart attack in the clinic | |
| Itescu et al. | Cell Therapy for Recapitulation of Vascular Network Formation and Functional Heart Muscle Recovery after Myocardial Ischemia |